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FURTHER STUDIES ON GLUCOPHYLLINE#
A. H. M a l o n e y , Ph.D., M.D., W a s h i n g t o n , D. C.
IN A PREVIOUS report on the diuretic activity of glucophylline by Maloney, Burton, and Robinson,1 in which experimental data were presented regard­
ing the action of this double salt of theophylline and methylglucamine, a 
xanthine compound exhibiting the very desirable properties of high diuretic 
efficiency with long duration of action, it was indicated that our study was 
being continued with the object of determining “ whether glucophylline exerts 
any untoward effects on the liver or kidney,”  The present report sets forth 
these and other pertinent results obtained from this investigation. The study 
was conducted in three parts, viz., the effect on (1) weight, (2) blood, and (3) 
vital organs. Full-grown dogs and immature rabbits were employed.
1. Weight, A, Dogs; Nine full-grown dogs, ranging in weight from 8.2 
to 11.5 kg., were divided into groups of three and treated with physiologic 
saline (controls), methylglucamine, and glucophylline, respectively. All the 
animals lost weight during the course of the fifty-four days of the experi­
mental period. The percentage loss in each group was 6.7, 9.3, and 11.6 in the 
order named. We do not think the medicaments played any significant role. 
The determinants here were probably the new diet and the unaccustomed arti­
ficial environment of the kennels (see Table I),
B. Rabbits: Thirty-six female rabbits, ranging in weight from 0.8 to 1.7 
kg., were employed. These were divided into three groups of twelve. Half 
of the animals in group 1 received no treatment whatever, while the other 
half received normal physiologic saline. These were used as two sets of con­
trols. Those in groups 2 and 3 received methylglucamine and glucophylline, 
respectively. For convenience, all animals received equal volumes of the sub* 
stances injected: the rabbits received 0.2 c.c. for the first period of thirty 
days and 0.4 c.c. for the second period of thirty days; the dogs, 1 c.c. through­
out the duration of the treatment. The methylglucamine was prepared as a 6.2 
per cent solution, so that each rabbit received 12.4 mg. and each dog 62 mg. of 
this salt per dose; the glucophylline was prepared as a 10 per cent solution (in 
the formula the ratio of methylglucamine to theophylline is 1:16 to 1:18), so 
that each rabbit received approximately 10 mg. for thirty days and 20 mg. 
later, and each dog received approximately 50 mg. of each of the two constitu­
ents in the compound. On the basis of the initial weight the milligram per 
kilogram dose was then computed for each animal. This figure appears in the 
respective tables. Injections were all made intraperitoneally once daily. All the 
animals in the two species were kept under similar environmental conditions
♦From the Department of Pharmacology, Howard University School of Medicine, W ash­
ington, D. C.
Received for publication, April 28, 1942.
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Table I
W eight Changes in Dogs
GROUP ANIMAL
DOSE
TOTAL
INITIAL
WEIGHT
(K G .)
54 DAYS 
FINAL 
WEIGHT 
(K G .)
%  DE­
CREASE
WEIGHT
LOSS
(K G .)
Control (Saline) 1 1 C.C. 8.3 7.7 7 0.6
2 1 C.C. 11.4 10.9 4 0.5
3 1 C.C. 11.1 10.1 9 1.0
Methylglucamine 4 6 mg./kg. 10.3 10.2 1 0.1
hydrochloride 5 6.7 mg./kg. 9.2 8.0 13 1.2
6 5.4 mg./kg. 11.5 9.9 14 1.6
Glucophylline 7 10.8 mg./kg. 9.2 6.93 25 2.3
8 10.1 mg./kg. 9.9 9.6 3 0.3
9 10.3 mg./kg. 9.8 9.1 7 0.7
and were provided at all times with an excess of food and water. Weights 
were recorded at weekly intervals. With the exception of one control rabbit, 
which died on the twenty-fourth day of the experimental period, all animals 
lived to the end and without exception appeared to maintain normal health 
throughout. The dogs in the glucophylline group (No. 3) were definitely more 
active and lively than the others. It is of interest to note that the animal care­
taker, who had no knowledge of what the animals being injected were receiv­
ing, volunteered the observation that the group of rabbits which we were 
treating with glucophylline ate more food and drank more water than those 
making up the other group; and that the amount of feces and urine voided by 
these animals was considerably greater. Reference to Table II reveals a 
fairly uniform average percentage of weight gains for the several groups both 
from the initial doses and after the doses were doubled. In the first series the 
order of percentage increases for the thirty-day period was : no medication, 
47; physiologic saline, 59; methylglucamine, 49.5; glucophylline, 49. By the 
end of the first thirty days, then, the animals in all groups had made sub­
stantial weight gains, some of them better than 50 per cent. This, no doubt, 
accounts for the gradual tapering off of weight increases during the second 
phase of the experiment when the doses were doubled. Most of the animals had 
already reached maturity, after which weight increase was due primarily to 
deposition of fat and only secondarily to actual body growth. The total group 
average percentage gains were: no medication, 136; saline, 150; methyl­
glucamine, 139; and glucophylline, 128.
2. Blood: Studies on blood changes included (1) erythrocytes, (2) white
blood cells, (3) differential, (4) nonprotein nitrogen, and (5) creatinine. One 
complete weekly determination was made on each dog during the fifty-four 
days of the experimental period. In the case of the rabbits there was one com­
plete weekly determination on each of eight animals, two within each group, 
the last being made at the time of disposition of the animal for histologic pur­
poses. As with the dogs, the figures appearing in Table III represent the com­
posite averages within each group. Included also in this table, for purposes 
of comparison, are figures of normal blood values for dogs and rabbits.*
♦Taken from figures compiled by Wagoner and Custer and reproduced in Tables I and 
i l l , pages 33 and 34 of their Handbook of Experimental Pathology, Springfield, 111., 1932, 
Charles C Thomas.
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Table II
W eight Changes in Rabbits
GROUP
ANI­
MAL
DOSE
TOTAL
INITIAL
WEIGHT
(K G .)
WEIGHT
IN 30 
DAYS 
(K G .)
%  IN ­
CREASE
DOSE
TOTAL
WEIGHT
ON
FINAL
DAY
(K G .)
TOTAL
IN ­
CREASE
WEIGHT
(K G .)
TOTAL
%
IN ­
CREASE
Control (a) No 1 0 0.88 Died
179medication 2 0 0.93 1.81 95 0 2.86 1.94
3 0 0.98 1.74 78 0 2.61 1.64 168
4 0 0.98 1.60 65 0 2.02 1.04 107
5 0 1.05 1.66 57 0 2.59 1.54 146
6 0 1.23 1.08 -12 0 2.20 0.97 80
(b) Physiologic 1 0.2 c.c. 1.23 1.82 49 0.4 c.c. 2.60 1.38 112 '
saline 2 0.2 c.c. 1.18 1.84 55 0.4 c.c. 2.55 1.38 116
3 0.2 c.c. 1.15 1.76 53 0.4 c.c. 2.57 1.42 1234 0.2 c.c. 1.05 1.75 66 0.4 c.c. 2.60 1.55 147
5 0.2 c.c. 0.95 1.58 66 0.4 c.c. 2.82 1.87 197
6 0.2 c.c. 0.80 1.32 65 0.4 c.c. 2.48 1.68 209
Methylglucamine mg./kg. mg./kg.
115hydrochloride 1 8.3 1.50 2.08 39 11.6 3.22 1.72
2 8.4 1.48 2.27 54 10.8 2.50 1.02 70
3 9.0 1.38 2.02 47 12.3 2.60 1.22 894 10.6 1.18 1.35 15 17.7 2.70 1.53 1305 10.8 1.15 ' 1.79 55 13.9 2.74 1.59 140
6 11.0 1.13 1.16 2 21.6 2.36 1.24 110
7 11.5 1.08 1.33 23 19.1 2.33 1.26 110
8 11.8 1.05 1.60 52 15.5 2.43 1.38 130
9 12.1 1.03 1.50 46 16.5 1.92 0.89 81
10 12.7 0.98 1.56 60 15.5 3.16 2.19 225
11 13.1 0.95 1.54 62 16.4 2.57 1.62 170
12 15.5 0.80 1.82 137 13.8 3.26 2.46 300
Glucophylline 1 11.5 1.75 2.24 21 17.9 3.56 1.81 103
2 12.5 1.60 2.34 45 17.1 3.25 1.65 103
3 14.3 1.40 2.05 45 19.5 2.82 1.62 100
4 14.3 1.40 2.12 50 18.9 3.24 1.84 132
5 16.1 1.24 1.95 57 20.5 2.95 1.71 137
6 16.7 1.20 1.96 63 20.4 2.67 1.47 121
7 16.7 1.20 1.82 50 21.9 2.76 1.56 130
8 16.7 1.20 1.62 35 24.9 2.65 1.45 120
9 17.4 1.15 1.62 42 24.9 2.49 1.34 116
10 18.2 1.10 1.58 44 25.0 2.79 1.69 153
11 18.2 1.10 1.78 62 22.2 2.93 1.83 166
12 20.0 1.00 1.73 73 |23.1 2.52 1.52 150
T a b l e  III
C o m p o s it e  B lo o d  V a l u e s  o f  D o g s  a n d  R a b b it s
ANIMAL R.B.C.MIL­
LIONS
W.B.C.
THOU­
SANDS
DIFFERENTIAL PERCENTAGE HB. N.P.N.
CREAT­
ININE
%
NUM ­
BER OF
VALUES % % SAM­
NEUT. LYMPH. MONO. EOS. BASOPH. PLINGS
Dog:
“ Normal
7.2 11.8 69 20 6 5 0.7 77 30.8 1.5 ?
values’ 
Saline 5.5 6.7 71 25 4 4 0 111 32.4 1.4 21
M-glucamine 5.3 8.5 70 26 6 0 0 109 26.1 1.3 21
Glucophylline 5.4 10.0 77 21 2 0 0 103 28.9 1.5 20
Rabbit: 5.6 7.9 43 42 9 2 4.0 95 31.0 1.11 ‘ Normal 
values ’
No medication 6.3 7.5 17 66 3 13 1 100 30.7 1.6 11
Saline 5.9 6.7 15 60 4 21 0 102 46.9 2.0 12
M-glucamine 5.5 8.1 10 68.5 5 16 0.5 104 38.1 2.0 20
Glucophylline 5.0 7.4 22 63.0 4 11 0 99 39.5 2.0 20
♦“Normal values” of blood (count and chemistry) reported above are taken from Tables 
I and III, respectively, from Wagoner, G., and Custer, R. P .; A Handbook of Experimental 
Pathology, Springfield, 111., 1932, Charles C Thomas.
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Table IV
SPEC. ANIMAL | BRAIN | LUNG | HEART | LIVER | KIDNEY | SPLEEN
T issue Changes in Dogs and Rabbits
A. Physiologic Salt Solution
10. Dog 2 No change No change Slight
cloudy
swelling
Slight
cloudy
swelling
Slight
cloudy
swelling
Slight pig­
mentation. 
Slight in­
creased cel- 
lularity in 
pulp
15. Rabbit A-4 No change Hyperemia, 
small focal 
hemor­
rhages
Focal areas 
of necrosis 
with con­
siderable 
inflamma­
tory reac-, 
tion
Cloudy
swelling
Degenera­
tion of tu­
bular epi­
thelium, 
especially 
in convo­
luted tu­
bules
Slight hy­
perplasia
17. Rabbit A-3 No change Slight hem­
orrhages
Cloudy
swelling
Slight
cloudy
swelling
Hyperemia; 
cloudy 
swelling
Marked hy­
peremia
B, Methylglucamine
7. Dog 4 No change No change Cloudy
swelling
Marked
cloudy
swelling
Cloudy
swelling
Hyperplasia
8. Dog 5 No change Diffuse hem­
orrhages 
throughout
No changes Cloudy
swelling
Cloudy 
swelling, 
marked in 
some 
tubules; 
necrosis 
in some 
tubules
Hyperplasia
11. Rabbit B-l Diffuse 
hemor­
rhages into 
alveoli, 
bronchi, 
and inter­
stitial tis­
sue
Marked hy­
peremia ; 
cloudy 
swelling
Cloudy
swelling
Hyperemia; 
cloudy 
swelling
19. Rabbit B-8 No change Small hem­
orrhages
Cloudy
swelling
Cloudy 
swelling; 
increase in 
periportal 
connective 
tissue
Marked hy­
peremia; 
cloudy 
swelling
Hyperemia
13. Rabbit B-12 Slight thick­
ening pf 
meninges. 
Focal hem­
orrhage—  
focal area 
of soften­
ing with 
cellular re­
action
Small hem­
orrhages ; 
arterio­
sclerosis
Multiple 
hemor­
rhages ; 
cloudy 
swelling
Cloudy
swelling
Cloudy 
swelling. 
Leucocytic 
infiltration 
in inter­
stitial tis­
sue of cor­
tex. Hyper­
emia
Hyperemia
5. Rabbit B-3 No change Hyperemia; 
arterio­
sclerosis
Small hem­
orrhages. 
Slight in­
crease in 
perivascu­
lar connec­
tive tissue
Cloudy 
swelling; 
passive hy­
peremia; 
maybe 
some fat
Cloudy
swelling
Slight hy­
perplasia
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Table IV — Cont ’d
SPEC. ANIMAL | BRAIN | LUNG | HEART | LIVER | KIDNEY | SPLEEN
C. Glucophylline
9. Dog 9 No change Hemor­
rhages in 
focal areas, 
cells with 
vacuolated 
cytoplasm 
in inter­
stitial tis­
sue. Sug­
gest fat, 
slight 
fibrosis
Cloudy
swelling
Cloudy
swelling
Cloudy
swelling
No change
12. Rabbit C-7 Hyperemia; 
infiltration 
of small 
and large 
monocytes 
in meninges
Small gran­
uloma
Slight
cloudy
swelling
Cloudy
swelling
Cloudy 
swelling; 
hyperemia; 
arterioscle­
rosis of 
small 
arteries
Slight hy­
perplasia
14. Rabbit C-2 No change Diffuse hem­
orrhages
Cloudy
swelling
Cloudy
swelling
No change Hyperplasia
18. Rabbit C-5 No change Hyperemia, 
few small 
hemor­
rhages
Cloudy 
swelling; 
small hem­
orrhages
Cloudy
swelling
Marked 
cloudy 
swelling; 
hyaline 
casts in 
collecting 
tubules
Slight hy­
perplasia
3. Histologic: Tissues fixed in 10 per cent formalin were prepared for
microscopic study from both sets of animals. The dogs were all disposed of 
on their last experimental day (the fifty-fourth) ; the rabbits were disposed in 
series of twos at ten-day intervals, beginning with the end of the first experi­
mental period on the thirtieth day. Thus, whereas the first group that were 
treated had received a single daily dose for thirty days, the second, third 
and fourth groups received this, followed afterward by a double dose daily 
at intervals of ten, twenty, and thirty days, respectively. Although these 
animals were exposed to unequal quantities of the drugs over varying periods 
of time, no appreciable differences could be demonstrated in the tissues studied. 
Pulmonary hemorrhages, demonstrable in most samples studied, were due to 
ante-mortem traumatic injury. Samples of brain, lung, heart, liver, kidney, 
and spleen were examined (see Table IY).
From these studies it is apparent that glucophylline neither disturbs the 
growth nor checks the normal increase in the weight of immature rabbits. 
Furthermore, with respect to both dogs and rabbits no noticeable difference 
could be observed in the general appearance of treated and untreated animals 
regarding health and general state of nutrition. In these respects all the groups 
exhibited the same general condition of health. The microscopic study revealed 
the presence of cloudy swelling as a rather constant finding in samples taken 
from both dogs and rabbits. This finding was quite as conspicuous in the 
tissues of animals used as controls, as it was in those of animals treated with 
methylglucamine and glucophylline. The blood samples taken from our rabbits 
showed an inordinately high differential eosinophilic count. This phenomenon
7
is a matter of not uncommon occurrence in the blood of laboratory animals. It 
is very probable that these cells, or many of them, were pseudo-eosinophiles or 
emphophiles. Referring to this type of cell, Wagoner and Custer2 make the 
observation that “ the analogue of the human neutrophile varies only in that 
the granules are larger than neutrophilic granules and take the acid stain by 
preference, although there is a slight affinity for the basic dye.”  Since this 
eosinophilic condition was uniformly present in each group, treated as well as 
untreated, we felt that we were dealing with cases of pseudo-eosinophilia and 
that these findings, therefore, were probably of no pathologic significance. 
Indeed, many a laboratory animal that appears to be normal and healthy in 
every respect has been found to exhibit visceral lesions exposed by the micro­
scope, if not grossly visible at autopsy. In the course of these studies one of 
the female dogs in our kennels gave birth to a litter of six pups. On the day 
after birth we began giving daily injections of glucophylline to three of these 
pups, using the other three as controls. No significant differences have been 
noticed, and at the end of thirty days the relative individual weights have 
shown uniform increases.
oratory studies on dogs and rabbits treated with methylglucamine and
glucophylline revealed:
1. Growth of immature rabbits is not disturbed. These animals made in­
creases in size and weight commensurate with normal controls.
2. The dogs, treated and controls, all lost weight—a condition due prob­
ably to food and housing restraint.
3. Histologic study of brain, heart, lung, spleen, kidney, and liver of both 
dogs and rabbits showed no harmful effects that might be attributed to 
the drug.
4. Significant figures setting forth results are appropriately tabulated.
W e wish to express thanks to Dr. Robert S. Jason and Dr. Bernard Kapiloff for personal 
assistance, and, to the Abbott Laboratories for providing- the drugs used in these experiments.
1. Maloney, A. H., Burton, A. F., and Robinson, J. W. L.: The Diuretic Action of Gluco­
phylline, J. L ab . & Clin . Med. 22: 600, 1937.
2. Wagoner, G., and Custer, R. P .: Handbook of Experimental Pathology, Springfield, 111..
1932, Charles C Thomas.
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